The global renal biomarker market is on a robust growth trajectory, projected to surge from USD 1,541.2 million in 2024 to an impressive USD 3,031.8 million by 2034. This growth represents a compound ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...